CUBE vs XGN · P/E 25, rev $1.07B vs rev $55.6M
CubeSmart (CUBE) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported XGN revenue for 2024-12-31 was $55.6M. Net income was -$15.1M. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. XGN currently screens at market cap $154.1M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. XGN currently screens at market cap $154.1M.
Not investment advice. Open the CUBE and XGN stock pages for the full models.
Not investment advice.